Renaissance Technologies’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
21,900
-37,600
| -63% | -$428K | ﹤0.01% | 3095 |
|
|
2025
Q1 | $707K | Buy |
+59,500
| New | +$707K | ﹤0.01% | 2595 |
|
|
2024
Q4 | – | Sell |
-246,400
| Closed | -$5.54M | – | 3792 |
|
|
2024
Q3 | $5.54M | Sell |
246,400
-77,600
| -24% | -$1.74M | 0.01% | 1383 |
|
|
2024
Q2 | $6.76M | Buy |
324,000
+144,700
| +81% | +$3.02M | 0.01% | 1127 |
|
|
2024
Q1 | $2.64M | Buy |
179,300
+64,100
| +56% | +$942K | ﹤0.01% | 1837 |
|
|
2023
Q4 | $1.19M | Buy |
115,200
+88,400
| +330% | +$912K | ﹤0.01% | 2291 |
|
|
2023
Q3 | $211K | Buy |
+26,800
| New | +$211K | ﹤0.01% | 3074 |
|
|
2023
Q2 | – | Sell |
-28,900
| Closed | -$257K | – | 4160 |
|
|
2023
Q1 | $257K | Sell |
28,900
-89,800
| -76% | -$799K | ﹤0.01% | 3176 |
|
|
2022
Q4 | $1.3M | Buy |
118,700
+45,400
| +62% | +$498K | ﹤0.01% | 2372 |
|
|
2022
Q3 | $955K | Sell |
73,300
-45,100
| -38% | -$588K | ﹤0.01% | 2526 |
|
|
2022
Q2 | $1.5M | Buy |
118,400
+42,200
| +55% | +$535K | ﹤0.01% | 2410 |
|
|
2022
Q1 | $1.07M | Buy |
+76,200
| New | +$1.07M | ﹤0.01% | 2684 |
|